At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 80 enrolled
Drug / intervention
Dexmedetomidine Injection +1 moredrug
Likely dose
Dexmedetomidine Injection 0.35 mcg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Traitement Des Frissons Lors de la césarienne Sous anesthésie péridurale Durant le Travail - un Essai Clinique randomisé Comparant la dexmédétomidine et la mépéridine
Centre hospitalier de l'Université de Montréal (CHUM)·interventional·Posted Apr 14, 2017·Updated May 27, 2022
In Brief
A Phase 3 clinical trial evaluating Dexmedetomidine Injection and Meperidine Injection for Cesarean Section Complications. Completed, enrolled 80 participants across 1 site.
Detailed Summary
Comparing two treatments for shivering after cesarean delivery for labor dystocia under epidural anesthesia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCesarean Section Complications
CountriesCanada
Collaborators--
Timeline
Phase 3CompletedFinished
201820192020202120222023202420252026
First PostedApr 2017
Enrollment StartMay 2017
Primary CompletionAug 2020
Study CompletionAug 2020
TodayJul 2026
First PostedApr 14, 2017
Enrollment StartMay 7, 2017
Primary CompletionAug 19, 2020
Study CompletionAug 20, 2020
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 9.2 years ago
Interventions
Dexmedetomidine Injectiondrug
0.35 mcg/kg intravenous in 2 minutes if shivering 5 minutes after delivery
Meperidine Injectiondrug
0.35 mg/kg intravenous in 2 minutes if shivering 5 minutes after delivery